Sun Pharma Q3 results show 16% profit growth and 1,100% dividend
pre-market1 source ↓written by the desknot a recommendation
- YoY
- ₹3,381 cr
- with revenue rising
- 13.5%
- ₹15,521 cr
- today
- 4%
- a high
- ₹1,655.80
Sun Pharma reported Q3 net profit up 16% YoY to ₹3,381 cr, with revenue rising 13.5% to ₹15,521 cr. The company declared an interim dividend of ₹11 per share. Shares rose 4% today, reaching a high of ₹1,655.80, reflecting strong market sentiment.
This solid performance highlights growth in India and emerging markets, potentially boosting investor confidence in the pharmaceutical sector.
Not investment advice. For informational purposes only.